Bioaffinity Technologies, INC. (BIAFW) — 10-Q Filings

10-Q Filings (6)

• bioAffinity's Losses Double Amid Revenue Dip, Cash Influx from Offerings — Nov 14, 2025 Risk: high
  bioAffinity Technologies, Inc. (BIAFW) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $11,772,288, up from $
• bioAffinity's Losses Widen Amid Revenue Drop, Going Concern Doubts — Aug 14, 2025 Risk: high
  bioAffinity Technologies, Inc. (BIAFW) reported a significant net loss of $6.72 million for the six months ended June 30, 2025, a substantial increase from the
• bioAffinity Technologies Q1 2025 10-Q Filing — May 15, 2025 Risk: medium
  bioAffinity Technologies, Inc. filed its quarterly report for the period ending March 31, 2025. The company, focused on commercial physical and biological resea
• bioAffinity Technologies Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  bioAffinity Technologies, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and operational a
• bioAffinity Technologies Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  bioAffinity Technologies, Inc. filed its 10-Q for the period ending June 30, 2024. The company, located in San Antonio, TX, is involved in commercial physical a
• bioAffinity Technologies Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  bioAffinity Technologies, Inc. (BIAFW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. bioAffinity Technologies, Inc. filed a 10-Q report for the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX